<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00710411</url>
  </required_header>
  <id_info>
    <org_study_id>DFG KFO-200</org_study_id>
    <nct_id>NCT00710411</nct_id>
  </id_info>
  <brief_title>Inflammatory Response After Muscle and Skeleton Trauma</brief_title>
  <acronym>IRAMST</acronym>
  <official_title>Inflammatory Response in Polytraumatized Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ulm</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Ulm</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the inflammatory response after multiple trauma in
      humans.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Polytraumatized patients are via a systemic inflammatory response syndrome at high risk for
      an uneventful outcome in the posttraumatic phase. One of the main functions of the
      inflammatory response is the recognition and elimination of damaged tissues and
      microorganisms. In polytraumatized patients, a huge amount of damaged cells occurs which has
      to be eliminated by programmed cell death (apoptosis)without damaging surrounding tissues. It
      remains unclear whether, when and how an interplay of complement system, NF-kB, danger and
      pattern recognition receptors, apoptosis, mesenchymal stem cells and their regulation may be
      beneficial and harmful. Differing activation of the complement system, pro-inflammatory
      biomarkers and predisposing polymorphisms of response and receptor genes are expected to lead
      to varying outcome. Therefore, this prospective observational study will enroll n=60
      polytraumatized patients with an ISS&gt;18 to monitor longitudinally their inflammatory response
      after trauma and to find out whether there is a discriminating pattern of the cross talk
      between complement system, biomarkers and apoptosis in patients with beneficial or harmful
      outcome.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Inflammatory pattern of complement activation, biomarkers and complement-regulating proteins (CRegs)on leukocytes</measure>
    <time_frame>0, 1, 4, 12, 24, 48, 96, 120 und 240 h after trauma</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>inflammatory biomarkers, cell surface markers, apoptosis, functional polymorphisms, mesenchymal stem cells, severity of injury (ISS), infections, SIRS, sepsis, shock, organ dysfunctions, severity of disease, ICU length of stay, wound healing, mortality</measure>
    <time_frame>0, 1, 4, 12, 24, 48, 96, 120 und 240 h after trauma for biochemical and immunological parameters; ISS on admission; scores on a daily basis; ICU and hospital death on discharge</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">48</enrollment>
  <condition>Multiple Trauma</condition>
  <arm_group>
    <arm_group_label>A, 2</arm_group_label>
    <description>Polytraumatized patients with ISS &gt; 18 and healthy controls</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, serum, white cells, and tissues will be retained.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Polytraumatized patients with an ISS &gt; 18 Controls: healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  multiple trauma injury, injury severity score (ISS) &gt; 18 with

               1. isolated fractures of the extremities

               2. fractures of the extremities combined with blunt/penetrating visceral trauma

               3. fractures of the extremities combined with blunt/penetrating thoracic trauma

               4. isolated head injury with morphological changes in CCT

               5. combination of points 1 - 4

                  Exclusion Criteria:

          -  life expectancy &lt; 24 hours

          -  participation in other trials

          -  ISS &lt; 18

          -  cardiopulmonary reanimation on the accident scene or dying immediately after hospital
             admission

          -  age &lt; 18 years

          -  known or suspected pregnancy

          -  patients with ray-treatment or chemotherapy within the last three months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manfred M Weiss, MD, MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinic of Anesthesiology, University Hospital Medical School, Steinhoevelstrasse 9, 89070 Ulm, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinic of Anesthesiology and Clinic of Traumatology, Hand-, Plastic-, and Reconstructive Surgery</name>
      <address>
        <city>Ulm</city>
        <zip>89070</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Huber-Lang M, Denk S, Fulda S, Erler E, Kalbitz M, Weckbach S, Schneider EM, Weiss M, Kanse SM, Perl M. Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro. Mol Immunol. 2012 Feb;50(1-2):60-5. doi: 10.1016/j.molimm.2011.12.005. Epub 2012 Jan 14.</citation>
    <PMID>22244896</PMID>
  </results_reference>
  <results_reference>
    <citation>Unnewehr H, Rittirsch D, Sarma JV, Zetoune F, Flierl MA, Perl M, Denk S, Weiss M, Schneider ME, Monk PN, Neff T, Mihlan M, Barth H, Gebhard F, Ward PA, Huber-Lang M. Changes and regulation of the C5a receptor on neutrophils during septic shock in humans. J Immunol. 2013 Apr 15;190(8):4215-25. doi: 10.4049/jimmunol.1200534. Epub 2013 Mar 11.</citation>
    <PMID>23479227</PMID>
  </results_reference>
  <results_reference>
    <citation>Denk S, Wiegner R, Hönes FM, Messerer DA, Radermacher P, Weiss M, Kalbitz M, Ehrnthaller C, Braumüller S, McCook O, Gebhard F, Weckbach S, Huber-Lang M. Early Detection of Junctional Adhesion Molecule-1 (JAM-1) in the Circulation after Experimental and Clinical Polytrauma. Mediators Inflamm. 2015;2015:463950. doi: 10.1155/2015/463950. Epub 2015 Oct 18.</citation>
    <PMID>26556956</PMID>
  </results_reference>
  <results_reference>
    <citation>Kozarcanin H, Lood C, Munthe-Fog L, Sandholm K, Hamad OA, Bengtsson AA, Skjoedt MO, Huber-Lang M, Garred P, Ekdahl KN, Nilsson B. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation. J Thromb Haemost. 2016 Mar;14(3):531-45. doi: 10.1111/jth.13208. Epub 2016 Feb 15.</citation>
    <PMID>26614707</PMID>
  </results_reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2008</study_first_submitted>
  <study_first_submitted_qc>July 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2008</study_first_posted>
  <last_update_submitted>December 16, 2015</last_update_submitted>
  <last_update_submitted_qc>December 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ulm</investigator_affiliation>
    <investigator_full_name>Manfred Weiss</investigator_full_name>
    <investigator_title>Professor, MD, MBA</investigator_title>
  </responsible_party>
  <keyword>humans</keyword>
  <keyword>patients</keyword>
  <keyword>polytrauma</keyword>
  <keyword>complement</keyword>
  <keyword>inflammation</keyword>
  <keyword>inflammatory response</keyword>
  <keyword>biomarkers</keyword>
  <keyword>cytokines</keyword>
  <keyword>cell surface markers</keyword>
  <keyword>apoptosis</keyword>
  <keyword>NF-kappaB</keyword>
  <keyword>functional polymorphisms</keyword>
  <keyword>mesenchymal stem cell</keyword>
  <keyword>severity of injury</keyword>
  <keyword>ISS</keyword>
  <keyword>infections</keyword>
  <keyword>systemic inflammatory response syndrome</keyword>
  <keyword>SIRS</keyword>
  <keyword>sepsis</keyword>
  <keyword>severe sepsis</keyword>
  <keyword>shock</keyword>
  <keyword>organ dysfunctions</keyword>
  <keyword>SOFA</keyword>
  <keyword>severity of disease</keyword>
  <keyword>APACHEII</keyword>
  <keyword>SAPSII</keyword>
  <keyword>SPAPS3</keyword>
  <keyword>length of stay</keyword>
  <keyword>wound healing</keyword>
  <keyword>outcome</keyword>
  <keyword>mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Trauma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

